TABLE 4

Odds ratios for the influence of antibodies to FV2 and merozoite antigens on pregnancy outcome in PM+ womena

AntigenOR (95% CI)
AnemiaHigh placental parasitemiaLBWPreterm delivery
FV20.726 (0.429, 1.229)0.432 (0.272, 0.687)* (P = 0.0004)0.444 (0.247, 0.799)* (P = 0.0068)0.590 (0.335, 1.040)
MSP1421.408 (0.768, 2.583)1.367 (0.828, 2.257)0.873 (0.468, 1.632)1.210 (0.641, 2.283)
MSP20.608 (0.289, 1.278)0.538 (0.272, 1.063)0.546 (0.256, 1.163)0.720 (0.329, 1.572)
MSP30.727 (0.405, 1.304)0.593 (0.361, 0.974) (P = 0.0389)1.268 (0.680, 2.363)0.927 (0.494, 1.737)
MSP110.653 (0.317, 1.346)1.197 (0.679, 2.108)1.547 (0.767, 3.123)2.168 (1.114, 4.222)
AMA10.777 (0.180, 3.354)0.216 (0.046, 1.019)0.990 (0.197, 4.981)0.410 (0.103, 1.636)
EBA-1750.690 (0.307, 1.553)0.444 (0.214, 0.920) (P = 0.0291)0.575 (0.263, 1.257)0.406 (0.188, 0.873) (P = 0.0211)
Pf410.685 (0.409, 1.149)0.486 (0.309, 0.765)* (P = 0.0018)0.832 (0.471, 1.469)0.722 (0.414, 1.257)
  • a ORs with 95% CIs reported were based on logistic models, adjusted for age and gravidity. The 95% CIs of ORs reaching outside 1.0 (highlighted in bold) were statistically significant. *, statistically significant ORs after Bonferroni correction for multiple comparisons among four pregnancy outcomes.